IL2/IL21 Region rs6822283: What Your Genotype Means
The rs6822283 variant is a single nucleotide polymorphism located in the intergenic region between the IL2 and IL21 genes. It has been identified in scientific studies as a genetic marker associated with a modified risk for certain autoimmune conditions.
What each genotype means
Typical autoimmune risk profile
This genotype represents the most common configuration at this location in the IL2/IL21 intergenic region. Research suggests this version is associated with a baseline level of risk for autoimmune conditions like rheumatoid arthritis, though individual risk is influenced by many other genetic and environmental factors.
Carried by the majority of individuals in European populations, where the minor allele frequency is approximately 10-15%.
Slightly altered risk profile
Carrying one copy of the T allele at this location has been statistically associated in some studies with a modified risk for certain autoimmune diseases, including rheumatoid arthritis and celiac disease. Because this association is based on population-level data, it does not predict the development of any specific condition for an individual.
Carried by approximately 1 in 5 to 1 in 4 people of European ancestry.
Increased autoimmune risk marker
This genotype is the less common variant at this location and has been identified in genetic studies as being associated with a different level of risk for autoimmune disorders compared to the more common C allele. Genetic associations of this type are complex and multifactorial; this result should not be interpreted as a medical diagnosis or a certainty of disease.
Carried by a small minority of individuals in European populations, consistent with a minor allele frequency of 10-15%.
Understanding the SNP and Its Location
A single nucleotide polymorphism, or SNP, is a variation at a single position in a DNA sequence among individuals. The variant rs6822283 is situated in the intergenic region between the IL2 and IL21 genes on chromosome 4. Intergenic regions are the stretches of DNA located between genes; while they do not code for proteins directly, they often contain regulatory elements that control how nearby genes are expressed. Because this SNP sits in a region critical for immune system signaling, researchers have focused on whether it influences the activity of the neighboring IL2 and IL21 genes, which are essential for the development and function of immune cells.
The Role of IL2 and IL21
The IL2 and IL21 genes are central to the immune system. IL2 (Interleukin-2) is a cytokine signaling molecule that regulates the activity of white blood cells, particularly T cells, which are vital for immunity. IL21 (Interleukin-21) is another cytokine that plays a complex role in the proliferation and maturation of various immune cells, including B cells and natural killer cells. Because these genes are so influential in orchestrating immune responses, variations in the DNA surrounding them are frequently studied in the context of autoimmune diseases, where the immune system may mistakenly target the body's own tissues. Understanding how this intergenic region functions is a major area of ongoing immunological research.
Research Associations and Evidence Strength
Scientific research, including genome-wide association studies (GWAS), has linked the IL2/IL21 region to altered risks for autoimmune conditions such as rheumatoid arthritis and celiac disease. However, the evidence strength for rs6822283 specifically is considered limited. While statistical associations have been observed in various cohorts, these findings do not imply a direct cause-and-effect relationship. Many factors, including other genetic variants and environmental triggers, contribute to the development of autoimmune diseases. Furthermore, the functional impact of this specific SNP remains a subject of investigation, as many non-coding variants identified in GWAS do not have a clearly defined biological mechanism. It is important to view these associations as statistical correlations rather than diagnostic indicators.
Population Frequency
The frequency of the minor allele for rs6822283 is approximately 10-15% in European populations. Genetic frequencies can vary significantly across different ancestral groups, and it is common for a variant that is prevalent in one population to be rare or absent in another. Researchers use these frequency data to better understand the evolutionary history of genetic variants and to ensure that genetic studies are representative of diverse human populations. Because this variant is relatively common in certain groups, it serves as a useful marker for large-scale genetic mapping, though its clinical relevance remains a topic for further scientific inquiry.
Interpreting Your Genetic Information
If you have information about your genotype for rs6822283, it is important to understand that this data is for educational purposes only. Genetic variants are just one piece of a much larger puzzle that includes your overall health history, lifestyle, and environment. This information cannot be used to diagnose a disease or predict your future health outcomes. If you have concerns about autoimmune symptoms or your family health history, the most appropriate step is to consult with a qualified healthcare professional. They can provide context based on your clinical presentation and help you navigate any necessary medical testing or management strategies. Never make changes to your health or medication regimen based on genetic data without professional guidance.
How common is this variant?
The minor allele frequency for rs6822283 is approximately 10-15% in European populations, with genotype distributions following standard Hardy-Weinberg expectations.
Frequently asked questions
Does having the rs6822283 variant mean I will get an autoimmune disease?
No. Genetic associations are statistical correlations, not destiny. Most people with this variant will never develop an autoimmune disease, as these conditions are complex and influenced by many genetic and environmental factors.
Can I use this SNP to test for rheumatoid arthritis?
No. This SNP is not a diagnostic test. Rheumatoid arthritis is diagnosed by clinicians based on physical exams, blood tests for inflammatory markers, and imaging, not by looking at a single genetic variant.
What should I do if I have the 'higher-attention' genotype?
You do not need to take any specific action. This classification simply reflects that the variant has been studied in the context of immune traits. Focus on maintaining a healthy lifestyle and discuss any specific health concerns with your doctor.
Is this variant related to how I respond to medication?
Some research has investigated whether the IL2/IL21 region influences responses to certain therapies in autoimmune patients. If you are currently taking medication, always discuss your treatment plan and any concerns about drug response with your prescribing physician or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/18/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs6822283?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL2
This variant shows borderline significance for association with celiac disease in the Dutch population.
This IL2 promoter variant has been associated with altered IL-2 production and immune-cell regulation, making it relevant to immune resilience and inflammatory disease susceptibility.